CD8A and lung adenocarcinoma: Based on previous research reports and our own research, we had found that low-dose anti-angiogenesis combined immunotherapy could achieve better anti-tumor effects, and the expression of LAYN on tumor-infiltrating CD8+T cells was negatively correlated with the prognosis of patients with lung adenocarcinoma.